Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis

Liknande verk

• Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials
  av: Bafadhel, M, et al.
  Publicerad: (2018)
• Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS)
  av: Bafadhel, M, et al.
  Publicerad: (2018)
• Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD
  av: Bafadhel, M, et al.
  Publicerad: (2018)
• Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
  av: Bafadhel M, et al.
  Publicerad: (2022-12-01)
• Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
  av: Bafadhel, M, et al.
  Publicerad: (2014)